NATHBIOGEN vs SANSTAR: Stock Comparison
Nath Bio-Genes (India) Limited vs Sanstar Limited
Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings
Sanstar Limited is the larger company by market capitalisation. Nath Bio-Genes (India) Limited shows a lower P/E, a higher dividend yield and faster revenue growth, while Sanstar Limited shows a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of Nath Bio-Genes (India) Limited and Sanstar Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Other Agricultural Products | Other Agricultural Products |
Price
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Live Price | ₹161.13 | ₹108.97 |
| Day Change | 4.19% | 2.85% |
| Volume | 19,108 | 2.05 L |
| 52-Week High | ₹204 | ₹137.49 |
| 52-Week Low | ₹126.15 | ₹74.3 |
| Distance from 52W High | -21.01% | -20.74% |
Valuation
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Market Cap | ₹301 Cr | ₹2,161 Cr |
| P/E Ratio | 7.43x | 57.22x |
| P/B Ratio | 0.45x | 2.84x |
| EPS | ₹20.97 | ₹1.89 |
| Book Value | ₹304.36 | ₹38.09 |
| Dividend Yield | 1.23% | 0% |
Growth
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Revenue Growth (TTM YoY) | -1% | -14.5% |
| EPS Growth (TTM YoY) | 0% | 244.6% |
| Qtr Sales Growth | -0.73% | -4.43% |
| Qtr Profit Growth | -101% | 17% |
Profitability & Leverage
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| ROE | 5.47% | 29.9% |
| ROCE | 7.1% | 29.2% |
| Net Margin | 9.35% | 5.5% |
| Operating Margin | 11.8% | 9.2% |
| Debt to Equity | 0.2x | 0.5x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Promoter Holding | 45.6% | 64.18%▼ 6.35 pp |
| FII Holding | 0.23%▼ 0.08 pp | 0.29%▲ 0.27 pp |
| DII Holding | 0.01% | 0.27%▼ 0.03 pp |
| Public Holding | 54.17%▲ 0.09 pp | 35.25%▲ 6.1 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Nath Bio-Genes (India) Limited and Sanstar Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.